FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum

INDSWFTLAB Share Price Discussion

Ind-Swift Laboratories Ltd.
Sector: Pharmaceuticals and health care
... Read more
INDSWFTLAB Long Term Analysts Rating
0/5 (0 Ratings)
INDSWFTLAB Share Price *
24.95 -0.05 (-0.2%)
* (quote may be delayed)

Find answers to all your questions on live INDSWFTLAB message board: Is INDSWFTLAB buy or sell? Should I buy INDSWFTLAB shares? Why are INDSWFTLAB shares falling? Should I invest in INDSWFTLAB stock?


INDSWFTLAB Discussion Forum

@newsbot • Reputation: 1,933
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
@newsbot • Reputation: 1,933
Like
reply
Reply
  • INDSWFTLAB - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization259.45
    Enterprise Value1,336.09
    Price to Earnings14.72
    Price to Book Value0.9
    Return on Capital Employed0.04
    Return on Equity0.06
    Face Value10
    Dividend YieldNA
  • INDSWFTLAB Share Price - Technicals

    keyboard_arrow_down
    INDSWFTLAB - 52 Week High₹52.7
    INDSWFTLAB - 52 Week Low₹21.95
  • INDSWFTLAB Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Jan 2224.225.324.224.8
    Jan 2124.9525.123.8525
    Jan 2024.42524.2524.5
    Jan 1724.752524.324.3
    Jan 1624.3525.3523.7524.75
  • INDSWFTLAB Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹24.09
    30 Day Moving Average₹24.01
    50 Day Moving Average₹29.99
    100 Day Moving Average₹31.37
    200 Day Moving Average₹36.19
  • INDSWFTLAB - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue731.29674.90.08
    Operating Profit124.9899.130.26
    Profit Before Tax28.58-56.23-1.51
    Net Income17.62-39.75-1.44
  • INDSWFTLAB - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Shareholder's Funds289.35229.180.26
    Total Liabilities1,822.52,008.03-0.09
    Total Assets2,111.852,237.21-0.06
  • INDSWFTLAB - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity71.4692.67-0.23
    Cash from Investing Activity-17.25-30.99-0.44
    Cash from Financing Activity-61.98-68.9-0.1
    Net Cash Flow-7.78-7.220.08
  • INDSWFTLAB - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.01-0.02
    Return on Equity0.06-0.17
    Return on Capital Employed0.040.02
  • INDSWFTLAB - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.13
    3 Year CAGR Growth in Operating Profit2.48
    3 Year CAGR Growth in EBIDTA1.46
    3 Year CAGR Growth in Net Income1.15
    3 Yr CAGR Growth - Diluted EPS1.13
  • INDSWFTLAB - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue-0.32
    5 Year CAGR Growth in Operating Profit1.34
    5 Year CAGR Growth in EBIDTA0.94
    5 Year CAGR Growth in Net Income1.15
    3 Yr CAGR Growth - Diluted EPS1.13
  • INDSWFTLAB - Recent News

    keyboard_arrow_down
  • INDSWFTLAB - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. S...
    Aurobindo Pharma Ltd. Sector: Pharma...
    Biocon Ltd. Sector: Pharmaceuticals ...
    Cipla Ltd. Sector: Pharmaceuticals a...
    Lupin Ltd. Sector: Pharmaceuticals an...
    Dr. Reddy's Laboratories Ltd. Sector...
    Piramal Enterprises Ltd. Sector: Phar...
    Glenmark Pharmaceuticals Ltd. Sector...
    Divi's Laboratories Ltd. Sector: Pha...
    Strides Pharma Science Ltd. Sector: P...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.